Ralpancizumab (Anti-PCSK9)
Ralpancizumab (Anti-PCSK9) is a monoclonal antibody targeting selective proprotein convertase subtilisin kexin 9 (PCSK9). It has the potential in hemorrhagic stroke, hypercholesterolemic, dyslipidemia treatment. MW 145.28 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A3022 |
| Sku # | A3022-1mg*5 |
| Pricing | 1mg*5, $1690.00 |